Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 8/2015

01-08-2015 | Original Article

Serum fibronectin 1 and ApoE levels increase with risk of lymphedema in Korean breast cancer survivors

Authors: Seung Yun Yim, Eunjung Ryu, Jae-Young Lim, Eun Joo Yang, Seung-Min Lee

Published in: Supportive Care in Cancer | Issue 8/2015

Login to get access

Abstract

Purpose

Lymphedema is an irreversible disorder often seen as a postoperative side effect in breast cancer survivors. We aimed to identify serum factors that are associated with lymphedema risk in breast cancer survivors.

Methods

This study recruited 60 volunteer breast cancer survivors. Participants were classified into either a CTRL group who underwent sentinel lymph node biopsy (SLNB), a RISK group who underwent axillary lymph node dissection (ALND) with removal of fewer than five lymph nodes, or an LE group who underwent ALND with removal of more than five lymph nodes. Bioimpedance was measured to determine the ratio of extracellular water (ECW) to total cellular water (TCW) and single-frequency bioimpedance analysis (SFBIA) ratios. Serum lipid profiles were compared among the groups using label-free quantitative proteomics with the nano-liquid chromatography (LC)-tandem mass spectrometer (MS/MS) and emPAI method.

Results

The CTRL, RISK, and LE groups had similar body weights and body mass indexes (BMIs) (<25 kg/m2). The LE group showed a higher grade of lymphedema severity compared to the RISK and CTRL groups. Lymphedema indices such as the ECW/TCW ratio and SFBIA ratio at 1 and 5 kHz were greatly increased in the LE group. Serum total cholesterol (total-C) level was higher in the LE group without affecting atherogenic index. Serum proteomics revealed that fibronectin 1 (FN1), apolipoprotein E (ApoE), antithrombin (ANT3), and complement C4 had different abundance values among the groups. ELISA confirmed that FN1 and ApoE were significantly elevated in both the RISK and LE groups compared to the CTRL group.

Conclusions

Changes in serum FN1 and ApoE levels were detected prior to changes in serum total-C level and lymphedema indices such as SFBIA ratio. Therefore, elevation in serum FN1 and ApoE concentrations could likely be used to monitor the risk of lymphedema in breast cancer survivors.
Appendix
Available only for authorised users
Literature
1.
Brennan MJ, DePompolo RW, Garden FH (1996) Focused review: postmastectomy lymphedema. Arch Phys Med Rehabil 77:S74–80CrossRefPubMed
2.
Carmichael AR (2006) Obesity as a risk factor for development and poor prognosis of breast cancer. BJOG Int J Obstet Gynaecol 113:1160–1166CrossRef
3.
4.
Dixon JB (2010) Lymphatic lipid transport: sewer or subway? Trends Endocrinol MetabTEM 21:480–487CrossRef
5.
Edwards TL (2000) Prevalence and aetiology of lymphoedema after breast cancer treatment in southern Tasmania. Aust N Z J Surg 70:412–418CrossRefPubMed
6.
Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL (2001) Arm edema in breast cancer patients. J Natl Cancer Inst 93:96–111CrossRefPubMed
7.
Fujikawa LS, Chan CC, McAllister C, Gery I, Hooks JJ, Detrick B, Nussenblatt RB (1987) Retinal vascular endothelium expresses fibronectin and class II histocompatibility complex antigens in experimental autoimmune uveitis. Cell Immunol 106:139–150CrossRefPubMed
8.
Golshan M, Martin WJ, Dowlatshahi K (2003) Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am Surg 69:209–211, discussion 212PubMed
9.
Gong Y, Xi GH, Keep RF, Hoff JT, Hua Y (2005) Complement inhibition attenuates brain edema and neurological deficits induced by thrombin. Acta Neurochir Suppl 95:389–392CrossRefPubMed
10.
Higashihara M, Kinoshita M, Teramoto T, Kume S, Kurokawa K (1991) The role of apoE in inhibitory effects of apoE-rich HDL on platelet function. FEBS Lett 282:82–86CrossRefPubMed
11.
International Society of L (2013) The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology 46:1–11
12.
Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, Rappsilber J, Mann M (2005) Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics MCP 4:1265–1272CrossRef
13.
Koo C, Innerarity TL, Mahley RW (1985) Obligatory role of cholesterol and apolipoprotein E in the formation of large cholesterol-enriched and receptor-active high density lipoproteins. J Biol Chem 260:11934–11943PubMed
14.
Kurkinen M, Vaheri A, Roberts PJ, Stenman S (1980) Sequential appearance of fibronectin and collagen in experimental granulation tissue. Lab Inv J Tech Methods Path 43:47–51
15.
Lim HY, Rutkowski JM, Helft J, Reddy ST, Swartz MA, Randolph GJ, Angeli V (2009) Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration. Am J Path 175:1328–1337PubMedCentralCrossRefPubMed
16.
Lim HY, Thiam CH, Yeo KP, Bisoendial R, Hii CS, McGrath KC, Tan KW, Heather A, Alexander JS, Angeli V (2013) Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL. Cell Metab 17:671–684CrossRefPubMed
17.
Matsuura F, Wang N, Chen W, Jiang XC, Tall AR (2006) HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. J Clin Invest 116:1435–1442PubMedCentralCrossRefPubMed
18.
McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol Off J Am Soc Clin Oncol 26:5213–5219CrossRef
19.
Petrek JA, Senie RT, Peters M, Rosen PP (2001) Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 92:1368–1377CrossRefPubMed
20.
Ramstrom M, Hagman C, Mitchell JK, Derrick PJ, Hakansson P, Bergquist J (2005) Depletion of high-abundant proteins in body fluids prior to liquid chromatography fourier transform ion cyclotron resonance mass spectrometry. J Proteome Res 4:410–416CrossRefPubMed
21.
Roses DF, Brooks AD, Harris MN, Shapiro RL, Mitnick J (1999) Complications of level I and II axillary dissection in the treatment of carcinoma of the breast. Ann Surg 230:194–201PubMedCentralCrossRefPubMed
22.
Rutkowski JM, Moya M, Johannes J, Goldman J, Swartz MA (2006) Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9. Microvasc Res 72:161–171PubMedCentralCrossRefPubMed
23.
Schirger A, Harrison EG Jr, Janes JM (1962) Idiopathic lymphedema. Review of 131 cases. JAMA J Am Med Assoc 182:14–22CrossRef
24.
Serena J, Blanco M, Castellanos M, Silva Y, Vivancos J, Moro MA, Leira R, Lizasoain I, Castillo J, Davalos A (2005) The prediction of malignant cerebral infarction by molecular brain barrier disruption markers. Stroke J Cereb Circ 36:1921–1926CrossRef
25.
Tabibiazar R, Cheung L, Han J, Swanson J, Beilhack A, An A, Dadras SS, Rockson N, Joshi S, Wagner R, Rockson SG (2006) Inflammatory manifestations of experimental lymphatic insufficiency. PLoS Med 3:e254PubMedCentralCrossRefPubMed
26.
27.
Wang J, Hao H, Yao L, Zhang X, Zhao S, Ling EA, Hao A, Li G (2012) Melatonin suppresses migration and invasion via inhibition of oxidative stress pathway in glioma cells. Journal of Pineal Research
28.
Ward LC (2006) Bioelectrical impedance analysis: proven utility in lymphedema risk assessment and therapeutic monitoring. Lymphat Res Biol 4:51–56CrossRefPubMed
29.
Ward LC, Bunce IH, Cornish BH, Mirolo BR, Thomas BJ, Jones LC (1992) Multi-frequency bioelectrical impedance augments the diagnosis and management of lymphoedema in post-mastectomy patients. Eur J Clin Investig 22:751–754CrossRef
30.
Warren AG, Janz BA, Slavin SA, Borud LJ (2007) The use of bioimpedance analysis to evaluate lymphedema. Ann Plast Surg 58:541–543CrossRefPubMed
31.
Werner RS, McCormick B, Petrek J, Cox L, Cirrincione C, Gray JR, Yahalom J (1991) Arm edema in conservatively managed breast cancer: obesity is a major predictive factor. Radiology 180:177–184CrossRefPubMed
32.
Xi G, Hua Y, Keep RF, Younger JG, Hoff JT (2001) Systemic complement depletion diminishes perihematomal brain edema in rats. Stroke J Cereb Circ 32:162–167CrossRef
33.
York SL, Ward LC, Czerniec S, Lee MJ, Refshauge KM, Kilbreath SL (2009) Single frequency versus bioimpedance spectroscopy for the assessment of lymphedema. Breast Cancer Res Treat 117:177–182CrossRefPubMed
34.
Zhu W, Smith JW, Huang CM (2010) Mass spectrometry-based label-free quantitative proteomics. J Biomed Biotechnol 2010:840518PubMedCentralPubMed
Metadata
Title
Serum fibronectin 1 and ApoE levels increase with risk of lymphedema in Korean breast cancer survivors
Authors
Seung Yun Yim
Eunjung Ryu
Jae-Young Lim
Eun Joo Yang
Seung-Min Lee
Publication date
01-08-2015
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 8/2015
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2588-2

Other articles of this Issue 8/2015

Supportive Care in Cancer 8/2015 Go to the issue

Original Article

Communication dysfunction, body image, and symptom severity in postoperative head and neck cancer patients: factors associated with the amount of speaking after treatment

Original Article

Decision-making preferences of Jordanian women diagnosed with breast cancer

Original Article

Baseline characteristics and concerns of female cancer patients/survivors seeking treatment at a Female Sexual Medicine Program

Review Article

The role of physical rehabilitation in stem cell transplantation patients

Original Article

Anxiety and depression symptoms in the 2 years following diagnosis of breast or gynaecologic cancer: prevalence, course and determinants of outcome

Original Article

“Oh, yeah, I’m getting closer to god”: spirituality and religiousness of family caregivers of cancer patients undergoing palliative care
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits